GTX
$17.50
Garrett Motion Inc., together with its subsidiaries, designs, manufactures, and sells engineered turbocharging and high-speed electric motor technologies for original equipment manufacturers, distributors, and industrial fields in the United States, Europe, Asia, and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Garrett Motion Inc., together with its subsidiaries, designs, manufactures, and sells engineered turbocharging and high-speed electric motor technologies for original equipment manufacturers, distributors, and industrial fields in the United States, ...
Recent News
Garrett Motion (GTX) Valuation Check After Recent Share Price Volatility
Garrett Motion (GTX) has been drawing attention after recent share price moves, with the stock down about 17% over the past month but still showing a modest gain over the past 3 months. See our latest analysis for Garrett Motion. The recent 17.22% 1-month share price decline, alongside a 4.27% 3-month share price return and a 100.33% 1-year total shareholder return, points to fading short-term momentum after a strong longer-term run. If Garrett Motion’s share price swings have you thinking...
Garrett Motion (GTX) Had a Remarkable 2025. Here’s Why
Alluvial Capital Management, an investment advisory firm, released its fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. The Fund delivered an exceptional quarter, returning 41.2%, making 2025 the best year since inception. The supportive market environment drove the performance of the Fund. The gains are highly concentrated in a small […]
Can Garrett Motion Sustain Its Turbocharger Momentum in 2026?
GTX racks up new turbocharger program wins across gasoline, hybrid and industrial platforms as it targets $1B in zero-emission tech revenue by 2030.
3 Small-Cap Stocks That Concern Us
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Apis Capital Trims Holdings of Celcuity Stock, According to Recent SEC Filing
Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology and strategic licensing in oncology.